Literature DB >> 11731620

New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation.

I Huez1, S Bornes, D Bresson, L Créancier, H Prats.   

Abstract

We recently demonstrated that the very long 5'-untranslated region (5'-UTR) of the vascular endothelial growth factor (VEGF) mRNA contains two independent internal ribosome entry sites (IRES A and B). In the human sequence, four potential CUG translation initiation codons are located in between these IRES and are in frame with the classical AUG start codon. By in vitro translation and COS-7 cell transfections, we demonstrate that a high mol wt VEGF isoform [called large VEGF (L-VEGF)] is generated by an alternative translation initiation process, which occurs at the first of these CUG codons. Using a bicistronic strategy, we show that the upstream IRES B controls the translation initiation of L-VEGF. This isoform is 206 amino acids longer than the classical AUG-initiated form. With a specific antibody raised against this NH2 extension, we show that the L-VEGF is present in different mouse tissues or in transfected COS-7 cells. We also demonstrate that L-VEGF is cleaved into two fragments: a 23-kDa NH2-specific fragment and a fragment with an apparent size similar to that of the classical AUG-initiated form. This cleavage requires the integrity of a hydrophobic sequence located in the central part of the L-VEGF molecule. This sequence actually plays the role of signal peptide in the classical AUG-initiated form. The AUG-initiated form and the COOH cleavage product of the L-VEGF are both secreted. In contrast, the large isoform and its NH2 fragment present an intracellular localization. These data unravel a further level of complexity in the regulation of VEGF expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731620     DOI: 10.1210/mend.15.12.0738

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  37 in total

Review 1.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 2.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

Review 3.  Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis.

Authors:  Peter S Yoo; Abby L Mulkeen; Charles H Cha
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

4.  Post-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation.

Authors:  Michael Jewer; Scott D Findlay; Lynne-Marie Postovit
Journal:  J Cell Commun Signal       Date:  2012-10-09       Impact factor: 5.782

5.  Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertile.

Authors:  Colin G Miles; Joan Slight; Lee Spraggon; Maureen O'Sullivan; Charles Patek; Nicholas D Hastie
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.

Authors:  Nathan D Montgomery; Della Yee; Stephanie A Montgomery; Terry Magnuson
Journal:  J Mol Biol       Date:  2007-10-22       Impact factor: 5.469

7.  The VEGF IRESes are differentially susceptible to translation inhibition by miR-16.

Authors:  Zeïneb S Karaa; Jason S Iacovoni; Amandine Bastide; Eric Lacazette; Christian Touriol; Hervé Prats
Journal:  RNA       Date:  2009-02       Impact factor: 4.942

8.  High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment.

Authors:  Wen-Yu Cheng; Chiung-Chyi Shen; Ming-Tsang Chiao; Yea-Jiuan Liang; Tsuo-Fei Mao; Bai-Shuan Liu; Jun-Peng Chen
Journal:  J Neurooncol       Date:  2018-06-16       Impact factor: 4.130

9.  Alternative-splicing-based bicistronic vectors for ratio-controlled protein expression and application to recombinant antibody production.

Authors:  Stéphanie Fallot; Raouia Ben Naya; Corinne Hieblot; Philippe Mondon; Eric Lacazette; Khalil Bouayadi; Abdelhakim Kharrat; Christian Touriol; Hervé Prats
Journal:  Nucleic Acids Res       Date:  2009-09-03       Impact factor: 16.971

10.  Nucleolar retention of a translational C/EBPalpha isoform stimulates rDNA transcription and cell size.

Authors:  Christine Müller; Anna Bremer; Sandra Schreiber; Sabrina Eichwald; Cornelis F Calkhoven
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.